Showing results (61-70 of 200) with videos related to
Sort By:
Pageof 20
Annals of Internal Medicine|September 1, 1988
Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entityJ D Hainsworth, D H Johnson, F A GrecoAnnals of Internal Medicine|April 1, 1986
Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndromeF A Greco, W K Vaughn, J D HainsworthThe Cancer Journal From Scientific American|November 1, 1995
Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedulesJ D Hainsworth, E L Raefsky, F A GrecoInvestigational New Drugs|January 1, 1997
Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignanciesJ D Hainsworth, S M Utley, F A GrecoSeminars in Oncology|July 7, 2001
Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancerJ D Hainsworth, H A Burris, F A GrecoCancer|June 15, 1996
Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinomaJ D Hainsworth, S L Stroup, F A GrecoJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experienceJ D Hainsworth, D H Johnson, F A GrecoAnnals of Internal Medicine|April 1, 1985
Extrahepatic biliary obstruction caused by small-cell lung cancerD H Johnson, J D Hainsworth, F A GrecoSeminars in Oncology|August 2, 2001
Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experienceJ D Hainsworth, H A Burris, F A GrecoPageof 20